Education
About Us
Working with TipRanks
Follow Us
Spago Nanomedical AB (DE:7UX)
FRANKFURT:7UX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 1.91M | kr 1.20M | kr 1.05M | kr 660.00K | kr 342.00K |
| Gross Profit | kr -12.36M | kr -23.28M | kr -15.60M | kr -16.78M | kr -416.00K |
| Operating Income | kr -33.71M | kr -42.51M | kr -39.47M | kr -39.19M | kr -18.96M |
| EBITDA | kr -33.40M | kr -42.22M | kr -38.73M | kr -38.69M | kr -18.59M |
| Net Income | kr -32.51M | kr -42.22M | kr -39.31M | kr -39.08M | kr -18.90M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 32.47M | kr 45.22M | kr 62.10M | kr 52.46M | kr 28.45M |
| Total Assets | kr 39.58M | kr 52.98M | kr 205.95M | kr 191.62M | kr 162.82M |
| Total Debt | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 |
| Net Debt | kr -32.47M | kr -45.22M | kr -62.10M | kr -52.46M | kr -28.45M |
| Total Liabilities | kr 2.28B | kr 11.67M | kr 8.80M | kr 6.81M | kr 3.15M |
| Stockholders' Equity | kr -2.24B | kr 41.32M | kr 197.16M | kr 184.81M | kr 159.67M |
| Cash Flow | |||||
| Free Cash Flow | kr -34.67M | kr -45.41M | kr -42.02M | kr -40.20M | kr -25.15M |
| Operating Cash Flow | kr -34.67M | kr -44.91M | kr -38.19M | kr -35.57M | kr -18.77M |
| Investing Cash Flow | kr -230.00K | kr -506.00K | kr -3.83M | kr -4.63M | kr -6.38M |
| Financing Cash Flow | kr 22.15M | kr 28.53M | kr 51.66M | kr 64.21M | kr 41.45M |
Spago Nanomedical AB Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.